Lineage Cell Therapeutics Inc Financial Flexibility Index
Lineage Cell Therapeutics Inc financial flexibility index. Lineage Cell Therapeutics Inc (LCTX) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of $-3.60 Million (operating CF $-3.62 Million minus capex $12.00K) represents 0% of total liabilities ($68.84 Million). See LCTX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lineage Cell Therapeutics Inc (1991–2024)
Financial flexibility index of Lineage Cell Therapeutics Inc from 1991 to 2024. Historical Financial Flexibility Index trend for Lineage Cell Therapeutics Inc across 34 annual periods. Check earnings quality score of Lineage Cell Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Lineage Cell Therapeutics Inc Financial Flexibility Index by Year (1991–2024)
Lineage Cell Therapeutics Inc financial flexibility index by year from 1991 to 2024. Year-by-year free cash flow to debt coverage for Lineage Cell Therapeutics Inc. For the full cash flow conversion analysis, see LCTX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.62x | $-22.53 Million | $-23.09 Million | $36.21 Million | ▲ +13.0% |
| 2023 | -0.72x | $-27.89 Million | $-28.57 Million | $39.00 Million | ▼ -2613.5% |
| 2022 | 0.03x | $1.47 Million | $1.06 Million | $51.73 Million | ▲ +110.3% |
| 2021 | -0.28x | $-23.21 Million | $-23.56 Million | $83.65 Million | ▲ +81.9% |
| 2020 | -1.54x | $-19.69 Million | $-19.75 Million | $12.82 Million | ▲ +30.6% |
| 2019 | -2.21x | $-31.51 Million | $-31.95 Million | $14.23 Million | ▲ +24.5% |
| 2018 | -2.93x | $-27.59 Million | $-30.88 Million | $9.41 Million | ▲ +9.8% |
| 2017 | -3.25x | $-29.19 Million | $-30.52 Million | $8.98 Million | ▲ +1.4% |
| 2016 | -3.30x | $-39.80 Million | $-42.33 Million | $12.06 Million | ▼ -53.2% |
| 2015 | -2.15x | $-39.21 Million | $-44.54 Million | $18.21 Million | ▲ +31.7% |
| 2014 | -3.15x | $-38.37 Million | $-38.85 Million | $12.18 Million | ▼ -79.0% |
| 2013 | -1.76x | $-27.23 Million | $-29.51 Million | $15.47 Million | ▲ +50.2% |
| 2012 | -3.53x | $-19.28 Million | $-19.68 Million | $5.45 Million | ▼ -22.3% |
| 2011 | -2.89x | $-12.63 Million | $-13.59 Million | $4.37 Million | ▼ -52.3% |
| 2010 | -1.90x | $-7.30 Million | $-7.73 Million | $3.85 Million | ▼ -7.8% |
| 2009 | -1.76x | $-4.20 Million | $-4.26 Million | $2.39 Million | ▼ -1172.3% |
| 2008 | -0.14x | $-744.37K | $-1.60 Million | $5.38 Million | ▲ +63.9% |
| 2007 | -0.38x | $-1.23 Million | $-1.24 Million | $3.22 Million | ▲ +23.0% |
| 2006 | -0.50x | $-1.25 Million | $-1.26 Million | $2.52 Million | ▲ +24.2% |
| 2005 | -0.66x | $-1.41 Million | $-1.41 Million | $2.16 Million | ▲ +49.8% |
| 2004 | -1.31x | $-1.54 Million | $-1.54 Million | $1.18 Million | ▼ -599.1% |
| 2003 | -0.19x | $-654.14K | $-654.14K | $3.50 Million | ▲ +76.6% |
| 2002 | -0.80x | $-2.13 Million | $-2.13 Million | $2.67 Million | ▲ +49.3% |
| 2001 | -1.57x | $-3.20 Million | $-3.21 Million | $2.04 Million | ▲ +88.3% |
| 2000 | -13.41x | $-4.82 Million | $-4.86 Million | $359.75K | ▼ -88.6% |
| 1999 | -7.11x | $-4.23 Million | $-4.39 Million | $595.51K | ▼ -42.2% |
| 1998 | -5.00x | $-2.00 Million | $-2.10 Million | $400.00K | ▼ -650.0% |
| 1997 | -0.67x | $-1.20 Million | $-1.30 Million | $1.80 Million | ▲ +93.7% |
| 1996 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▲ +0.0% |
| 1995 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▼ -121.1% |
| 1994 | -4.75x | $-1.90 Million | $-2.00 Million | $400.00K | ▲ +70.3% |
| 1993 | -16.00x | $-1.60 Million | $-1.60 Million | $100.00K | ▼ -23.1% |
| 1992 | -13.00x | $-1.30 Million | $-1.30 Million | $100.00K | ▼ -333.3% |
| 1991 | -3.00x | $-600.00K | $-600.00K | $200.00K | — |